Actively Recruiting
Evaluating the Safety and Effectiveness of Robot-Assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
Led by Shandong University · Updated on 2024-12-27
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the flexible auxiliary single-arm transluminal endoscopic robot FASTER system to see if it can improve the safety and effectiveness of endoscopic submucosal dissection ESD for early gastric cancer. The study aims to find out whether using the FASTER system reduces muscular injuries and shortens procedure and dissection times compared to the traditional ESD method. This pilot randomized controlled study is led by Shandong University. Participants will be randomly assigned to one of two groups one group will receive ESD with the help of the FASTER system, while the other will undergo the conventional ESD procedure. Both procedures focus on treating early-stage stomach cancers by carefully removing affected tissue. The FASTER system is designed to provide better tissue traction for safer and more efficient dissection. During the study, participants will keep a diary to record symptoms after their procedure. Researchers will monitor safety by measuring the number of muscular injuries within 24 hours after ESD. They will also assess several other outcomes such as bleeding during the procedure, the time required for hemostasis, procedure duration, and success rates of tissue removal. The study involves careful follow-up within the first day after treatment to evaluate these factors.
CONDITIONS
Brief Title
Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
Research Team
X
Xiuli Zuo Professor, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
